Loading...
Derniers dépôts
-
Gilles Freyer, Anne Floquet, Olivier Tredan, Aurore Carrot, Carole Langlois-Jacques, et al.. Bevacizumab, olaparib, and durvalumab in patients with relapsed ovarian cancer: a phase II clinical trial from the GINECO group. Nature Communications, 2024, 15 (1), pp.1985. ⟨10.1038/s41467-024-45974-w⟩. ⟨hal-04549309⟩
-
Guillaume Pontarollo, Maxime Bonjour, Thomas Walter, Mathieu Pioche, Pierre-Marie Lavrut, et al.. Histopronostic factors in superficial colorectal adenocarcinomas treated by endoscopy: reproducibility and impact of immunohistochemistry and digital pathology. Virchows Archiv, 2024, ⟨10.1007/s00428-023-03722-3⟩. ⟨hal-04547807⟩
-
L. Monteiro Martins, E. Coz, Celine Piegay, Arnaud Friggeri, Ms. Hacid, et al.. Environmental predictors and emergency hospital admissions in Lyon, France: an analysis using the distributed lag non-linear model (DLNM). EPICLIN 2024, 18ème Conférence francophone d’Épidémiologie Clinique, 31èmes journées des statisticiens des centres de lutte contre le cancer, May 2024, Dijon, France. 72, pp.202505, 2024, ⟨10.1016/j.jeph.2024.202505⟩. ⟨hal-04576996⟩
-
Damien Roussel, Karine Salin, Adeline Dumet, Caroline Romestaing, Benjamin Rey, et al.. Oxidative phosphorylation efficiency, proton conductance and reactive oxygen species production of liver mitochondria correlates with body mass in frogs. Journal of Experimental Biology, 2015, 218, pp.3222-3228. ⟨10.1242/jeb.126086⟩. ⟨hal-01327786⟩
Nombre de documents
2 035
Nombre de notices
5 115
Répartition par type de documents
Evolution